Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis

Rheumatology (Oxford). 2018 May 1;57(5):934-936. doi: 10.1093/rheumatology/kex507.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Giant Cell Arteritis / complications
  • Giant Cell Arteritis / drug therapy*
  • Glucocorticoids / pharmacology*
  • Humans
  • Interleukin-17 / antagonists & inhibitors
  • Remission Induction / methods*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Interleukin-17
  • secukinumab